The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Open accessAbstract
Nonalcoholic steatohepatitis (NASH) may present with increased hepatic fibrosis progressing to end-stage liver disease. No factors that determine increasing fibrosis and histologically advanced disease have been recognized, thus, liver biopsy is recommended in all patients for diagnosis and prognosis. Our aim was to identify independent predictors of severe hepatic fibrosis in patients with NASH. One hundred and forty-four patients were studied. All patients underwent liver biopsy. Clinical and biochemical variables were examined with univariate and multivariate analysis. Thirty-seven (26%) patients had no abnormal fibrosis, 53 (37%) had mild fibrosis, 15 (10%) had moderate fibrosis, 14 (10%) had bridging fibrosis, and 25 (17%) had cirrhosis. In multivariate analysis, older age (P= .001), obesity (P= .002), diabetes mellitus (P= .009), and aspartate transaminase/alanine transaminase (AST/ALT) ratio greater than 1 (P= .03) were significant predictors of severe liver fibrosis (bridging/cirrhosis). Body mass index (P= .003) was the only independent predictor of the degree of fat infiltration. Increased transferrin saturation correlated positively with the severity of fibrosis (P= .02) in univariate analysis, and there was a trend for more female patients among those with more advanced fibrosis (P= .09). However, iron studies or gender were not significant when controlled for age, obesity, diabetes, and AST/ALT ratio. In conclusion, older age, obesity, and presence of diabetes mellitus help identify those NASH patients who might have severe liver fibrosis. This is the subgroup of patients with NASH who would be expected to derive the most benefit from having a liver biopsy and considering investigational therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Classification and Diagnosis of Diabetes
Fajans, S. S. (1990) · Medical Entomology and Zoology · Cited by 2,359
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473 · cited 2×
“Ferritin (μg/L) 229 (24-1520) 242 (6-1639) 194 (11-1000) .”
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 810
Cited by
Items 101–196 of 196
Obesity-Associated Liver Disease
Marchesini, G., Moscatiello, S., Di Domizio, S., & Forlani, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1399 · Cited by 359
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
Dyson, J. K., Anstee, Q. M., & McPherson, S. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100403 · Cited by 357
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Shimada, M., Hashimoto, E., Taniai, M., Hasegawa, K., Okuda, H., Hayashi, N., Takasaki, K., & Ludwig, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00099-5 · Cited by 356
Tang, A., Desai, A., Hamilton, G., Wolfson, T., Gamst, A., Lam, J., Clark, L., Hooker, J., Chavez, T., Ang, B. D., et al. (2015) · Radiology · doi:10.1148/radiol.14140754 · Cited by 356
NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
Nobili, V., Marcellini, M., Devito, R., Ciampalini, P., Piemonte, F., Comparcola, D., Sartorelli, M. R., & Angulo, P. (2006) · Hepatology · doi:10.1002/hep.21262 · Cited by 352
Self-citationNonalcoholic fatty liver disease: A review of current understanding and future impact
Charlton, M. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00440-9 · Cited by 350
Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography
Yoneda, M., Suzuki, K., Kato, S., Fujita, K., Nozaki, Y., Hosono, K., Saito, S., & Nakajima, A. (2010) · Radiology · doi:10.1148/radiol.10091662 · Cited by 348
Treatment of non-alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.042200 · Cited by 346
Self-citationQuantification of Liver Fat with Magnetic Resonance Imaging
Reeder, S. B., & Sirlin, C. B. (2010) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2010.08.013 · Cited by 342
Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
KIM, C. H., & YOUNOSSI, Z. M. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.10.721 · Cited by 340
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340
Non‐alcoholic steatohepatitis in type 2 diabetes mellitus
GUPTE, P., AMARAPURKAR, D., AGAL, S., BAIJAL, R., KULSHRESTHA, P., PRAMANIK, S., PATEL, N., MADAN, A., AMARAPURKAR, A., & HAFEEZUNNISA (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03312.x · Cited by 329
Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment
Smith, B. W., & Adams, L. A. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.72 · Cited by 327
Watanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1050-7 · Cited by 327
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis
Berzigotti, A., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Morillas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., et al. (2011) · Hepatology · doi:10.1002/hep.24418 · Cited by 325
Recent concepts in non‐alcoholic fatty liver disease
Adams, L. A., & Angulo, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01748.x · Cited by 324
Self-citationEffects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients
Ong, J. P., Elariny, H., Collantes, R., Younoszai, A., Chandhoke, V., Reines, H. D., Goodman, Z., & Younossi, Z. M. (2005) · Obesity Surgery · doi:10.1381/0960892053576820 · Cited by 322
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 320
Kanwal, F., Kramer, J. R., Li, L., Dai, J., Natarajan, Y., Yu, X., Asch, S. M., & El‐Serag, H. B. (2020) · Hepatology · doi:10.1002/hep.31014 · Cited by 319
“Several studies support the relationship between metabolic traits like diabetes and obesity and the likelihood of developing nonalcoholic steatohepatitis (NASH) and advanced fibrosis(5-8)— both surrogates of progressive disease in NAFLD.”
BackgroundMoylan, C. A., Pang, H., Dellinger, A., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley-Koch, A. E., Choi, S. S., Michelotti, G. A., et al. (2014) · Hepatology · doi:10.1002/hep.26661 · Cited by 316
Chalasani, N., Guo, X., Loomba, R., Goodarzi, M. O., Haritunians, T., Kwon, S., Cui, J., Taylor, K. D., Wilson, L., Cummings, O. W., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.057 · Cited by 315
Update on Nonalcoholic Fatty Liver Disease
McCullough, A. J. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200203000-00013 · Cited by 315
Dowman, J. K., Tomlinson, J. W., & Newsome, P. N. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04556.x · Cited by 312
Hepatic steatosis in obese patients: clinical aspects and prognostic significance
Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E., & Marchesini, G. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00126.x · Cited by 312
Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications
Ma, X., Holalkere, N.-S., R, A. K., Mino-Kenudson, M., Hahn, P. F., & Sahani, D. V. (2009) · RadioGraphics · doi:10.1148/rg.295085186 · Cited by 312
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
Loaeza-del-Castillo, A., Paz-Pineda, F., Oviedo-Cárdenas, E., Sánchez-Ávila, F., & Vargas-Vorácková, F. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31836-8 · Cited by 311
Assessment of Hepatic Steatosis by Expert Pathologists: The End of a Gold Standard
El-Badry, A. M., Breitenstein, S., Jochum, W., Washington, K., Paradis, V., Rubbia-Brandt, L., Puhan, M. A., Slankamenac, K., Graf, R., & Clavien, P.-A. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bcd6dd · Cited by 307
Stepanova, M., Rafiq, N., & Younossi, Z. M. (2010) · Gut · doi:10.1136/gut.2010.213553 · Cited by 303
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
Wieckowska, A., & Feldstein, A. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091983 · Cited by 300
Nonalcoholic Fatty Liver Disease in Severely Obese Subjects
Gholam, P. M., Flancbaum, L., Machan, J. T., Charney, D. A., & Kotler, D. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01041.x · Cited by 296
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
Loria, P., Adinolfi, L. E., Bellentani, S., Bugianesi, E., Grieco, A., Fargion, S., Gasbarrini, A., Loguercio, C., Lonardo, A., Marchesini, G., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.021 · Cited by 294
Adams, L. A., Harmsen, S., St. Sauver, J. L., Charatcharoenwitthaya, P., Enders, F. B., Therneau, T., & Angulo, P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.18 · Cited by 293
Self-citationHistological assessment of non‐alcoholic fatty liver disease
Hübscher, S. G. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02416.x · Cited by 292
Preiss, D., & Sattar, N. (2008) · Clinical Science · doi:10.1042/cs20070402 · Cited by 292
Estimation of Hepatic Proton-Density Fat Fraction by Using MR Imaging at 3.0 T
Yokoo, T., Shiehmorteza, M., Hamilton, G., Wolfson, T., Schroeder, M. E., Middleton, M. S., Bydder, M., Gamst, A. C., Kono, Y., Kuo, A., et al. (2011) · Radiology · doi:10.1148/radiol.10100659 · Cited by 290
Nonalcoholic Fatty Liver Disease
Adams, L. A., & Lindor, K. D. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.05.013 · Cited by 289
Self-citationNon-alcoholic fatty liver disease
Smith, B. W., & Adams, L. A. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.596521 · Cited by 285
Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
Syn, W.-K., Oo, Y. H., Pereira, T. A., Karaca, G. F., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., Guy, C. D., Fearing, C. M., et al. (2010) · Hepatology · doi:10.1002/hep.23599 · Cited by 283
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Masuoka, H. C., & Chalasani, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12016 · Cited by 283
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Non-Alcoholic Fatty Liver Disease in Older People
Frith, J., Day, C. P., Henderson, E., Burt, A. D., & Newton, J. L. (2009) · Gerontology · doi:10.1159/000235677 · Cited by 282
Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.327 · Cited by 280
Steatosis as a Risk Factor in Liver Surgery
Vetel??inen, R., van Vliet, A., Gouma, D. J., & van Gulik, T. M. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000225113.88433.cf · Cited by 281
Yuan, J., Govindarajan, S., Arakawa, K., & Yu, M. C. (2004) · Cancer · doi:10.1002/cncr.20427 · Cited by 275
Daniels, S. J., Leeming, D. J., Eslam, M., Hashem, A. M., Nielsen, M. J., Krag, A., Karsdal, M. A., Grove, J. I., Neil Guha, I., Kawaguchi, T., et al. (2019) · Hepatology · doi:10.1002/hep.30163 · Cited by 273
Noninvasive evaluation of NAFLD
Castera, L., Vilgrain, V., & Angulo, P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.175 · Cited by 273
Self-citationEkstedt, M., Franzén, L. E., Mathiesen, U. L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.013 · Cited by 272
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Kang, S. H., Lee, H. W., Yoo, J.-J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0178 · Cited by 267
What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?
Fan, J., Saibara, T., Chitturi, S., Kim, B. I., Sung, J. J. Y., Chutaputti, A., & NAFLD, T. A. W. P. F. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04952.x · Cited by 267
Nonalcoholic Fatty Liver Disease: A Clinical Review
Sass, D. A., Chang, P., & Chopra, K. B. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1267-z · Cited by 267
Garcia-Monzón, C., Martín-Pérez, E., Iacono, O. L., Fernández-Bermejo, M., Majano, P. L., Apolinario, A., Larrañaga, E., & Moreno-Otero, R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80301-3 · Cited by 265
Pathogenesis and management issues for non-alcoholic fatty liver disease
Duvnjak, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i34.4539 · Cited by 264
KIRSCH, R., CLARKSON, V., SHEPHARD, E. G., MARAIS, D. A., JAFFER, M. A., WOODBURNE, V. E., KIRSCH, R. E., & HALL, P. D. L. M. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03198.x · Cited by 262
Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation
Frühbeck, G., Catalán, V., Rodríguez, A., Ramírez, B., Becerril, S., Salvador, J., Colina, I., & Gómez-Ambrosi, J. (2019) · Nutrients · doi:10.3390/nu11020454 · Cited by 262
Nonalcoholic fatty liver disease: An agenda for clinical research
Younossi, Z. M., Diehl, A. M., & Ong, J. P. (2002) · Hepatology · doi:10.1053/jhep.2002.32483 · Cited by 261
Comparison of blood tests for liver fibrosis specific or not to NAFLD
Calès, P., Lainé, F., Boursier, J., Deugnier, Y., Moal, V., Oberti, F., Hunault, G., Rousselet, M. C., Hubert, I., Laafi, J., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.035 · Cited by 260
Liver fibrosis scores predict liver disease mortality in the United States population
Unalp‐Arida, A., & Ruhl, C. E. (2017) · Hepatology · doi:10.1002/hep.29113 · Cited by 260
Body mass index as a predictor of hepatic steatosis in living liver donors
Rinella, M. E., Alonso, E., Rao, S., Whitington, P., Fryer, J., Abecassis, M., Superina, R., Flamm, S. L., & Blei, A. T. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23787 · Cited by 259
Metabolic disturbances in non-alcoholic fatty liver disease
Byrne, C. D., Olufadi, R., Bruce, K. D., Cagampang, F. R., & Ahmed, M. H. (2009) · Clinical Science · doi:10.1042/cs20080253 · Cited by 258
Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet
Ito, M., Suzuki, J., Tsujioka, S., Sasaki, M., Gomori, A., Shirakura, T., Hirose, H., Ito, M., Ishihara, A., Iwaasa, H., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00008.x · Cited by 253
Chalasani, N., Wilson, L., Kleiner, D. E., Cummings, O. W., Brunt, E. M., & Ünalp, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.016 · Cited by 253
Miele, L., Vallone, S., Cefalo, C., La Torre, G., Di Stasi, C., Vecchio, F. M., D’Agostino, M., Gabrieli, M. L., Vero, V., Biolato, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.008 · Cited by 249
Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
Tanaka, N., Sano, K., Horiuchi, A., Tanaka, E., Kiyosawa, K., & Aoyama, T. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31815591aa · Cited by 248
“Similarly to obesity and related metabolic disorders, such as impaired glucose tolerance and dyslipidemia, NASH is becoming a common type of chronic hepatitis both in Japan and worldwide(1,2) and may progress to cirrhosis and ultimately develop into hepatocellular carcinoma or hepatic failure.(3-6) In addition, NASH p…”
BackgroundAllard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247
Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis
TAVARES DE ALMEIDA, I., CORTEZ-PINTO, H., FIDALGO, G., RODRIGUES, D., & CAMILO, M. E. (2002) · Clinical Nutrition · doi:10.1054/clnu.2001.0529 · Cited by 243
Povero, D., Panera, N., Eguchi, A., Johnson, C. D., Papouchado, B. G., de Araujo Horcel, L., Pinatel, E. M., Alisi, A., Nobili, V., & Feldstein, A. E. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.07.007 · Cited by 221
Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., Burt, A. D., & Day, C. P. (2005) · Gut · doi:10.1136/gut.2004.057968 · Cited by 219
The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity
O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009997 · Cited by 211
“Recent studies indicate that the histological severity of NAFLD correlates with the indices of the metabolic syndrome, particularly degree of insulin resistance[40,41].”
BackgroundNonalcoholic fatty liver disease
Erickson, S. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800089-jlr200 · Cited by 194
The evolving role of liver sinusoidal endothelial cells in liver health and disease
McConnell, M. J., Kostallari, E., Ibrahim, S. H., & Iwakiri, Y. (2023) · Hepatology · doi:10.1097/hep.0000000000000207 · Cited by 189
“Aging is associated with a progressive decline in liver function and augmented incidence and severity of chronic liver diseases(39–41).”
Rosenberg, P., Urwitz, H., Johannesson, A., Ros, A.-M., Lindholm, J., Kinnman, N., & Hultcrantz, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.024 · Cited by 185
Non‐alcoholic steatohepatitis (NASH): where are we now and where are we going?
Day, C. P. (2002) · Gut · doi:10.1136/gut.50.5.585 · Cited by 181
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177
Pathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
ter Borg, P. C. J., Schalm, S. W., Hansen, B. E., & van Buuren, H. R. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00699.x · Cited by 160
Wrede, C. E., Buettner, R., Bollheimer, L. C., Schölmerich, J., Palitzsch, K.-D., & Hellerbrand, C. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02083 · Cited by 161
Kawaguchi, K., Sakaida, I., Tsuchiya, M., Omori, K., Takami, T., & Okita, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.038 · Cited by 160
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery
Xanthakos, S. A., Jenkins, T. M., Kleiner, D. E., Boyce, T. W., Mourya, R., Karns, R., Brandt, M. L., Harmon, C. M., Helmrath, M. A., Michalsky, M. P., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.039 · Cited by 151
“First, this is an adolescent cohort and more severe NASH is associated with advancing age.(22) Thus, the adolescent with NASH may be presenting for bariatric surgery before progression to more active NASH or significant fibrosis has occurred.”
BackgroundMirza, M. S. (2011) · ISRN Gastroenterology · doi:10.5402/2011/592404 · Cited by 148
Ucar, F., Sezer, S., Erdogan, S., Akyol, S., Armutcu, F., & Akyol, O. (2013) · Redox Report · doi:10.1179/1351000213y.0000000050 · Cited by 143
Gan, L., Chitturi, S., & Farrell, G. C. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/831536 · Cited by 135
“Relevant factors include age (especially over age 50 years), BMI > 28–32 kg/m2, insulin resistance or T2D, and raised serum ALT [13, 14, 27, 57, 85–91].”
Vallin, M., Guillaud, O., Boillot, O., Hervieu, V., Scoazec, J.-Y., & Dumortier, J. (2014) · Liver Transplantation · doi:10.1002/lt.23936 · Cited by 137
Boland, M. L., Oró, D., Tølbøl, K. S., Thrane, S. T., Nielsen, J. C., Cohen, T. S., Tabor, D. E., Fernandes, F., Tovchigrechko, A., Veidal, S. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4904 · Cited by 129
Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis
Ahmed, U. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i34.4651 · Cited by 121
Treatment of non-alcoholic fatty liver disease.
(2007) · PubMed Central · Cited by 118
Effect of Bariatric Surgery on Liver Fibrosis
Moretto, M., Kupski, C., da Silva, V. D., Padoin, A. V., & Mottin, C. C. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0559-y · Cited by 110
Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia
Sankatsing, R. R., Fouchier, S. W., de Haan, S., Hutten, B. A., de Groot, E., Kastelein, J. J. P., & Stroes, E. S. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176191.64314.07 · Cited by 106
“0001 GGT (U/L) 25 (18-43) 25 (18-43) 19 (15-35) 0.”
Nonalcoholic fatty liver disease – current status and future directions
Demir, M., Lang, S., & Steffen, H. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12291 · Cited by 105
Alanine Aminotransferase Decreases with Age: The Rancho Bernardo Study
Dong, M. H., Bettencourt, R., Barrett-Connor, E., & Loomba, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014254 · Cited by 103
Role of iron in hepatic fibrosis: One piece in the puzzle
Philippe, M. A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4746 · Cited by 95
Recent advances in nonalcholic fatty liver disease
Greenfield, V., Cheung, O., & Sanyal, A. J. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbccf2 · Cited by 94
Corey, K. E., Klebanoff, M. J., Tramontano, A. C., Chung, R. T., & Hur, C. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4044-2 · Cited by 84
Aging and the Biological Response to Liver Injury
Marzioni, M., Pinto, C., Ninfole, E., Gaggiano, L., Benedetti, A., & Maroni, L. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402033 · Cited by 36
Evidence-Based Medicine and the Problem of Healthy Volunteers
Marchesini, G., Marchignoli, F., & Petta, S. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5272 · Cited by 13
Effect on Liver Enzymes of Biliopancreatic Diversion: 4 Years of Follow-Up
Aller, R., Pacheco, D., Izaola, O., Primo, D., & de Luis, D. A. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000375506 · Cited by 10
Metadata
- Authors
- Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D.
- Venue
- Hepatology
- Published
- 1999-12
- Volume
- 30
- Issue
- 6
- Pages
- 1356-1362
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1996559225
- Cited by
- 1,610
- References
- 49
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.